v3.26.1
Inventory - Narrative (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Dec. 31, 2025
[1]
Inventory [Line Items]    
Inventories - current $ 112,542 $ 101,060
Inventories-noncurrent 345,026 $ 342,232
Inventory incurred prior to FDA approval $ 39,100  
Minimum    
Inventory [Line Items]    
Period of lower average per unit cost of materials (in months) 6 months  
Maximum    
Inventory [Line Items]    
Period of lower average per unit cost of materials (in months) 35 months  
[1] The condensed consolidated balance sheet at December 31, 2025 has been derived from the audited consolidated financial statements at that date.